Background {#Sec1}
==========

Vitamin B~12~ (cobalamin, VB~12~) is one of the most structurally complex natural Vitamins. VB~12~ is only produced by some bacteria and archaea and it requires more than 30 enzymes for the de novo synthesis of VB~12~ \[[@CR1], [@CR2]\]. VB~12~ plays an important role as an essential co-factor in various biochemical processes such as DNA synthesis, fatty acid synthesis, amino acid metabolism and energy production \[[@CR3], [@CR4]\]. VB~12~ has been widely used in food and medicine fields \[[@CR5]\], and the global demand for VB~12~ in these applications has been growing rapidly \[[@CR6], [@CR7]\]. A considerable number of enhancement and development of natural products mainly rely on mutagenesis and screening strategies \[[@CR8]\], while targeted engineering strategies by gene overexpression or deletion do not always generate desired results due to the complexity of highly regulated metabolic networks.

In order to screen libraries with high genetic diversity, a key problem is developing smart screening methods. Traditional methods suffer from low dynamic range, low throughput and unwanted sensitivity to variable experimental parameters \[[@CR9]\]. Fluorescence-activated cell sorting (FACS) allows ultrahigh throughput in cell sorting and requires a sortable signal output by biosensors in individual cells that respond to various intracellular concentrations of the target molecule with a correlation \[[@CR10]\]. Developing a biosensor sensitive to VB~12~ concentration is thus very important.

Riboswitches are small structured mRNA elements that regulate gene expression and translation in response to specific small molecule ligands \[[@CR11]\]. They act as relatively simple and direct metabolite sensors that are capable of both molecular recognition and transducing this information by altering protein expression \[[@CR12]--[@CR14]\]. Natural riboswitches are found with the highest frequency in the 5'-UTR of bacterial mRNAs, where they regulate the expression of downstream genes through structural changes undergone in response to the binding of a specific target molecule.

VB~12~ riboswitch has been found to widely regulate VB~12~ biosynthesis in bacteria \[[@CR15]\]. Expression of cob operon in cobalamin biosynthetic pathway and transporter encoding gene *btuB* are repressed by the presence of vitamin B12, in particular. The VB~12~ riboswitch consists of a binding region (aptamer domain) and an expression platform that modulates gene expression \[[@CR16], [@CR17]\]. Upon ligand binding, the aptamer region undergoes a conformational change that is interpreted by the expression platform (Fig. [1](#Fig1){ref-type="fig"}), resulting in repressed gene expression \[[@CR18], [@CR19]\]. Comparative analysis of the genes and regulatory regions from different bacterial genomes is a powerful approach allowing the identification of regulatory patterns \[[@CR20]\]. Using this approach, Vitreschak et al. have summarized approximately 200 VB~12~-elements from 67 bacterial genomes \[[@CR21]\], providing candidates for biosens or development.

In this study, we screened a sensitive riboswitch to sense the amount of intracellular VB~12~ concentration of single cells by FACS and developed a VB~12~ high-throughput screening system. Using this novel VB~12~ screening system, high yield VB~12~ producing strains were screened and identified from a mutant library of *S. meliloti* generated by ARTP. Moreover, genomic analysis of the high yield VB~12~ producing strain allowed us to give insight into the mechanism of VB~12~ regulation pathways which would guide future study.Fig. 1Mechanism of riboswitch based intracellular vitamin B~12~. In the simplified example cells containing a very low concentration or none of the VB~12~ (green circle), the ribosome binding site (RBS) is unstructured. Under a higher concentration of target metabolite, the aptamer domain undergoes restructuring forming a hairloop to attenuate gene expression

Methods {#Sec2}
=======

Strains and culture conditions {#Sec3}
------------------------------

The initial strain, *S. meliloti 320*, was stored in our laboratory \[[@CR22]\]. *S. meliloti 320* was grown in LB medium supplemented with MgCl~2~ (2.5 mM) and CaCl~2~ (2.5 mM) (LB/MC medium), or minimal M9 medium supplemented with 1 μg/mL biotin and 10 ng/mL CoCl~2~, as well as 0.1% sucrose for liquid medium or 0.2% sucrose for solid medium (unless indicated otherwise), respectively, (named M9/sucrose) \[[@CR23]\]. And the strain was grown at 30 °C with shaking at 200 rpm. Antibiotics were used as follows: spectinomycin (Sm; 200 μg/mL for *E. coli* and 600 μg/mL for *S. meliloti*), gentamicin (Gm; 10 μg/mL for *E. coli*, 20 μg/mL for *S. meliloti*), and kanamycin (Km; 50 μg/mL for *E. coli* and 100 μg/mL for *S. meliloti*).

Genetic techniques {#Sec4}
------------------

For construction of *Sm320-N8* strain, genetic deletions in *S. meliloti* 320 genome were generated by homologous recombination and allelic replacement. Two fragments of cobI-left and -right flanking DNA sequences (Additional file [1](#MOESM1){ref-type="media"}: Table S1) were ligated by overlap extension polymerase chain reaction (PCR), and the PCR product was cloned into a suicide vector pJQ200SK carrying *sacB* and gentamicin resistance gene. The construct was introduced into *S. melilothi* by triparental mating with help of the mobilizing strain MT616 \[[@CR24]\] carrying pRK600, and the culture was plated onto LB/MC-agar containing gentamicin. A second reciprocal recombination event was selected on LB/MC-agar containing 5% sucrose, and then isolates with the desired deletions were subsequently screened by PCR verification in which primers hybridizing outside the cloned flanking sequences were used to amplify the deletion region.

Riboswitch sensor construction and validation {#Sec5}
---------------------------------------------

To construct riboswitch sensor plasmids, the promoter PmelA was amplified from pSymB megaplasmid, the approximately 200 bp VB~12~ riboswitch sequence containing a riboswitch and RBS from different strains were obtained by artificial synthesis (riboswitch sequences were provided in Additional file [1](#MOESM1){ref-type="media"}: Table S2), and the genes were amplified by PCR. Fragments containing PmelA promoter, VB~12~ riboswitch sequence and GFP reporter gene were fused by PCR. Next, the pBHR1 plasmid and the fused PCR fragments were ligated by Gibson assembly at 50 °C for 1 h, and then cloned in *E. coli* strain *DH5α*. Detailed constructions of the riboswitch-containing plasmids are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S2 and Additional file [1](#MOESM1){ref-type="media"}: Table S2. The plasmids were then separately transferred into *Sm320*, *Sm320-N8* and *Sm320-L6* (engineered mutants with different production capacities) by triparental mating. *S. meliloti* containing P~melA~-riboswitch-gfp plasmid was grown at 30 °C for 12 h, and then transferred into shake flask fermentation with 10% (v/v) of inoculation for 3 days. The samples were harvested with centrifuging at 4000 g for 8 min, followed by washing in PBS for three times. The cells were collected to measure their GFP fluorescence by flow cytometry \[[@CR9]\].

The flow cytometry (MoFlo XDP, Beckman, USA) was performed with a 488-nm excitation laser and FL1, respectively. The data were analyzed with Summit software. Eight riboswitches were selected based on the sequence reported by Vitreschak et al. This method was also used to characterize the other 7 strains. The strains and plasmids used in this study are presented in Table [1](#Tab1){ref-type="table"} and sequences of primers are listed in Table S1 in the Additional file [1](#MOESM1){ref-type="media"}.Table 1Strains and plasmids used and constructed in this studyStrain or plasmidRelevant characteristicsSources of referenceStrains Sm320*Sinorhizobium meliloti 320,* VB~12~ producing strain.\[[@CR22]\] Sm320-L6*Sm320* derivative, carrying plasmid pBR-OhemE to reduce production capacityThis study Sm320-N8*Sm320* derivative, knocking out *cobI* geneThis study Sm320-Mybi*Sm320* derivative, carrying plasmid pBR- SYB-lacI and plasmid pMB-gfp was used in the ARTP treatThis study MT616MT607/pRK600; *Escherichia coli* helper strain for mobilizing RK2/RP4-derived plasmids\[[@CR24]\]Plasmid pJQ200skVector for construction of deletions, *sacB*,Gm^R^\[[@CR31]\] pMB393Broad-host-range vector, P~tauA~ promoter,Amp^R^\[[@CR32]\] pBHR1Broad-host-range vector, Derivative of PBBR122,Km^R^This lab pBR- EC-butBpBHR1 plasmid carrying EC-butB riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- PF-cbiBpBHR1 plasmid carrying PF-cbiB riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- SM-bluBpBHR1 plasmid carrying SM-bluB riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- SM-cobUpBHR1 plasmid carrying SM-cobU riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- MLO-bluBpBHR1 plasmid carrying MLO-bluB riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- MLO-metEpBHR1 plasmid carrying MLO-metE riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- SY-btuBpBHR1 plasmid carrying SY-btuB riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- BI-cbiWpBHR1 plasmid carrying BI-cbiW riboswitch were cloned in front of a *gfp* reporter gene driven by the constitutive promoter P~melA~This study pBR- SYB-lacIpBHR1 plasmid carrying SY-btuB riboswitch were cloned in front of a *lacI* reporterThis study pMB-gfppMB393 containing *lacO* and carrying *gfp* reporterThis study pBR-OhemEpBHR1 plasmid carrying *hemE* gene to reduce production capacityThis study

Mutagenesis by ARTP and determination of optimal treatment time {#Sec6}
---------------------------------------------------------------

Pure helium was used as the plasma working gas for ARTP mutation and the operating parameters were as follows: (1) the radio frequency power input was 100 W; (2) the distance between the plasma torch nozzle exit and the sample plate was 4 mm; and (3) the temperature of the plasma jet was below 30 °C \[[@CR25]\]. Under these operating conditions, the ARTP mutagenesis dosage was only dependent on the treatment time.

To determine the optimal treatment time, *S. meliloti* was cultured for 72 h (mid-log phase) and then subjected to ARTP treatment. Briefly, 10 μL culture (1 × 10^8^ cells/mL) was treated with the helium-based ARTP for 15, 30, 60, 75, 90 and 120 s. Lethality rate was calculated for determining the appropriate treatment time. The culture without treatment was used as a control. After each treatment, the steel plate was eluted with sterile distilled water into new tubes and properly diluted, incubated on fermentation medium at 30 °C for 1 h, and then cultured on solid medium with 600 μg/mL spectinomycin at 30 °C for 4 days. The lethality rate was determined as follows:$$\documentclass[12pt]{minimal}
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Whole genome sequencing {#Sec7}
-----------------------

The genomic DNA of strain *S. meliloti 320* was extracted from bacterial cells grown overnight in LB/MC medium at 30 °C and 200 rpm. The DNA was extracted using OMEGA Bacterial DNA kits (Omega bio-tek, Feyou Biotechnology, China) following the manufacturer's protocol \[[@CR26], [@CR27]\]. To verify DNA quality, PCR amplifications were performed in a final volume of 50 μL, containing 10 μM each primer, 1.25 units of Q5 High-Fidelity DNA polymerase (New England Biolabs, USA), dNTP mixture (250 μM each dNTP), and approximately 50 ng of template DNA. The PCR amplification conditions consisted of an initial denaturation for 10 min at 94 °C, followed by 30 cycles of denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s, and extension at 72 °C for 1 min with a final extension of 10 min at 72 °C. The quality and quantity of DNA were analyzed using 1% agarose gel electrophoresis and spectrophotometric method, respectively. The verified genomic DNA was selected for further analysis.

Analytical methods {#Sec8}
------------------

Biomass was determined with a spectrophotometer at 600 nm. The sample for measuring cell concentrations was obtained as follows: 1 mL of broth was centrifuged at 10,000×g for 10 min, the supernatant was discarded, and the cell pellets were resuspended in 1 mL of 0.85% NaCl buffer. The concentrations of the principal fermentation products were determined by high performance liquid chromatography (HPLC) \[[@CR28]\]. The sample (25 mL) was mixed with 2.5 mL of NaNO~2~ 8% (*w*/*v*) and 2.5 mL of glacial acetic acid. The mixtures were boiled for 30 min, and then centrifuged. The supernatants were filtrated through a 0.22-μm membrane filter. Then, 20 μl of NaCN 10% (w/v) was added to 1 mL of the aqueous phase. 20 μL of the final sample was injected into an Agilent 1260 HPLC with a 5C18-250A column (Agilent, 4.6 mm id × 250 mm, 5 μm) thermostated at 35 °C. The mobile phase consists of water and acetonitrile (70:30 \[v/v\]) at 0.8 mL/min \[[@CR22]\]. Samples were detected at 361 nm. All values presented in this study were averages of at least three independent trials.

Preparation of cell extracts and detection of the amount of intracellular VB~12~ {#Sec9}
--------------------------------------------------------------------------------

Centrifugation was used to sediment 500 μL of cell suspension through 100 μL silicone oil on the bottom of the tube. Cell pellets were then resuspended by 200 μL perchloric acid (20%, v/v) by gentle vortexing after disruption by sonication. After breaking up the cells, extracts were neutralized by addition of 200 μL Na~2~CO~3~ and the membrane materials and denatured proteins were removed by centrifugation. Then, 100 μL of NaNO~2~ 8% (*w*/*v*) and 100 μL of glacial acetic acid were added to 1 mL of aqueous phase, and the mixture was boiled for 30 min, centrifuged and the supernatant was filtrated through a filter membrane (0.22 μm), and then 2 μl of NaCN 10% (w/v) was added to 100 μl of the aqueous phase. The samples were stored in − 20 °C for VB~12~ analysis by HPLC. The amount of intracellular VB~12~ was calculated as the mill grams of intracellular VB~12~ per liter of culture.

Fermentations {#Sec10}
-------------

The fermentation medium contained (per liter of deionized water): sucrose 60 g/L; corn steep liquor (CSL) 20 g/L; betaine 6 g/L; ammonium sulfate 2 g/L; potassium dihydrogen phosphate 2.6 g/L; cobalt chloride 0.06 g/L; and 0.1 g/L DMB was added to the medium. The pH before autoclaving was adjusted to 7.0--7.4. The stock sugar solution was autoclaved separately before mixing with the rest of the medium.

For cultivating VB~12~-producing strains in microtiter plates, colonies were cultivated in 100 μL LB/MC medium overnight using 96-well microtiter plates (Corning Costar 3930, square U-bottom, 350 μL) and then 10% (v/v) inocula was transferred to 2 mL fermentation medium using 24-well deep microtiter plates (Corning Costar 3524, square U-bottom, 5 mL) at 30 °C, 700 rpm, 80% humidity in a Microtron shaker (Infors, China).

For shake flask fermentation, the seed culture was grown at 30 °C for 12 h and was used to provide 10% (v/v) inocula for fermentation. Experiments were conducted in 250 mL Erlenmeyer flasks containing 30 mL of each medium at 30 °C at an agitation rate of 200 rpm in rotary shakers for 7 days. The samples were used to determine cell mass (OD600 nm), residual sugars every 24 h, and product at 7 days.

Results {#Sec11}
=======

Engineered mutants with different production capacities of VB~12~ {#Sec12}
-----------------------------------------------------------------

To evaluate the dose-response of riboswitches on transcriptional regulation under variable the amount of intracellular VB~12~ levels, we engineered mutants of the original *S. meliloti* production strain *Sm320* with different production capacities. The complete VB~12~ biosynthetic pathway contains approximately 30 genes (Fig. [2a](#Fig2){ref-type="fig"}) and deleting any of them will prevent VB~12~ biosynthesis. Strain *Sm320-N8* with an in-frame deletion of essential VB~12~ biosynthetic gene *cobI* was constructed as a negative control strain that does not produce VB~12~. To construct mutant with low production capacity, we overexpressed gene *hemE* encoding the key enzyme in the heme branch pathway to reduce VB~12~ biosynthesis. This strain was named *Sm320-L6*. The VB~12~ concentration of the original strain *Sm320* and the two derivatives, *Sm320-N8* and *Sm320-L6*, were measured by HPLC. The total amounts of VB~12~ produced by strains *Sm320-N8*, *Sm320-L6* and *Sm320* were 0, 65.21 and 126.28 mg/L with 7d's cultivation, respectively, the amounts of intracellular VB~12~ of strains *Sm320-N8*, *Sm320-L6* and *Sm320* were 0, 9.65 and 18.5 mg/L (Fig. [2b](#Fig2){ref-type="fig"}, [c](#Fig2){ref-type="fig"}). The details of cell growth are provided in Additional file [1](#MOESM1){ref-type="media"}: Figure S1. It was important to note that the amounts of intracellular VB~12~ was used to indicate the intracellular VB~12~ level, and but was not the real intracellular VB~12~ concentration.Fig. 2Constructed engineered mutants with different production capacities. **a** Oxygen-dependent VB~12~ biosynthetic pathway in *S. meliloti*. The branched biosynthesis of heme is also depicted. **b** The concentration of VB~12~ in producer strains in fermentation broth was determined by HPLC. Different colors represent the different strains. Values shown are HPLC-determined and are the means of three independent fermentation cultures for each strain. **c** the amount of intracellular VB~12~ in recombinant strains in (**b**)

Construction of riboswitch-based VB~12~ sensors {#Sec13}
-----------------------------------------------

To identify a sensitive element that allows efficient screening of positive mutants with high VB~12~ production, eight different potential riboswitches (Table [2](#Tab2){ref-type="table"}) were selected according to the criteria described above, plasmids containing VB~12~-dependent riboswitches coupled to a GFP reporter were separately transformed into *Sm320*, *Sm320-L6* and *Sm320-N8*, then the expression levels of GFP under the control of the eight riboswitches were compared. The strains containing the plasmids were grown at 30 °C for 12 h and were used to provide shake flask fermentation for 3 days with 10% (v/v) inoculant and then tested for GFP expression by flow cytometry (Fig. [3](#Fig3){ref-type="fig"}).Table 2Conserved RNA elements upstream of some B~12~-regulated genesGenome abbreviationsThe start codonProximal downstream genesCoding of enzyme proteinCBL biosynthesis Propionibacterim freudenreichii (PF)285*cbiB*VB~12~ biosynthesis protein Bacillus megaterium(BI)266*cbiW*VB~12~ biosynthesis protein Mesorhizobium loti(MLO)233*bluB*5,6-dimethylbenzimidazole synthase Sinorhizobium meliloti(SM)251*bluB*5,6-dimethylbenzimidazole synthase Sinorhizobium meliloti(SM)227*cobU*adenosylcobinamide kinaseVitamin B12 transport Escherichia coli(EC)248*btuB*VB~12~ transporter BtuB Salmonella typhimurium(SY)252*btuB*VB~12~ transporter BtuBB12-dependent or alternative metabolic pathways Mesorhizobium loti(MLO)309*metE*5-methyltetrahydropteroyltriglutamate\--homocysteine methyltransferaseFig. 3Flow diagram of constructed VB~12~ riboswitches. The ideal phenotypes were selected from a VB~12~ riboswitch library. VB~12~ sensor constructs were made that contained a predicted riboswitch and a GFP reporter. The fermentation broth was collected and analyzed by Fluorescence Activated Cell Sorting

Figure [4](#Fig4){ref-type="fig"} shows the GFP fluorescence of different *S. meliloti* strains carrying different riboswitches. The strains containing riboswitches shown in Fig. [4](#Fig4){ref-type="fig"}-[b](#Fig4){ref-type="fig"}, [c](#Fig4){ref-type="fig"}, [d](#Fig4){ref-type="fig"}, [e](#Fig4){ref-type="fig"} and [h](#Fig4){ref-type="fig"} exhibited a similar fluorescence intensity, although they could produce different levels of VB~12~. Fig. [4](#Fig4){ref-type="fig"}-[g](#Fig4){ref-type="fig"} shows that the fluorescence intensity of different *S. meliloti* strains containing SY-btuB-gfp plasmid were sensitive to the increasing amount of intracellular VB~12,~ while the other strains in Fig. [4](#Fig4){ref-type="fig"}-[a](#Fig4){ref-type="fig"}, [f](#Fig4){ref-type="fig"}, [g](#Fig4){ref-type="fig"} exhibited a negative correlation between their fluorescence intensity and the amounts of intracellular VB~12~. The results indicated that some of these predicted riboswitches indeed responded to the concentrations of VB~12~ in *S. meliloti*. Thus, we further examined the feasibility of using the SY-btuB riboswitch as a sensitive sensor for VB~12~ concentration.Fig. 4Validation and selection of a sensitive element that allows efficient identification of positive mutants. Fluorescence-activated cell sorting results of engineered VB~12~ producing strains with different production capacity (*Sm320-N8*, *Sm320-L6,* and *Sm320*) were tested separately with eight riboswitches. Fig. **a**-**h** exhibited *S. meliloti*strains carrying different riboswitches, and the genome abbreviations of eight different potential riboswitches were marked in the top left corner of the figures

Examination of the SY-btuB riboswitch sensor {#Sec14}
--------------------------------------------

We attempted to demonstrate the feasibility of the sensor for screening hyperproducing strains from a library. As SY-btuB VB~12~ riboswitch is a repressive type of selector, the single *gfp* reporter gene was substituted with a "dual-repression" mode that contained a *lacI* repressor protein and a *gfp* reporter gene (Fig. [5a](#Fig5){ref-type="fig"}). We tested this reconstructed sensor in strains *Sm320*, *Sm320-L6* and *Sm320-N8*. A positive correlation between the GFP fluorescence and the VB~12~ productivity of the strains was showed by flow cytometry (Fig. [5c](#Fig5){ref-type="fig"}).Fig. 5Validation of feasibility of riboswitch SY-btuB in different performances. **a** Mechanism of VB~12~ dependent riboswitch SY-btuB double plasmid work mode. VB~12~ directly binds to the riboswitch region, producing a conformational change in the secondary structure of mRNA, and thus inhibiting *lacI* gene expression and causing the *gfp* reporter to show a fluorescent signal. For cells containing a very low concentration of VB~12~, the ribosome binding site (RBS) is unstructured. This allows for efficient translation of *lacI* gene and then *lacI* and can bind *lacO* and repress *gfp* expression. **b** The microscopic image of *S. meliloti 320* and fluorescence microscopic images of *Sm320, Sm320-L6* and *Sm320-N8* cells carrying SY-btuB sensor plasmid, respectively. **c** FACS (Fluorescence Activated Cell Sorting) results of three strains mixed with equal optical density. Strains exhibiting top 1% of the fluorescence values were selected by FCM. The screened strains were then distinguished the selected colonies by Summit 5.2 analysis

In order to verify the response behavior of the new sensor system to the amount of intracellular VB~12~ level, GFP fluorescence was observed by fluorescence microscope (DM5000B, Leica, Germany). A very weak fluorescence value was detected for the samples without VB~12~, and there was a corresponding increase in GFP fluorescence value along with the increase amount of intracellular VB~12~ (Fig. [5b](#Fig5){ref-type="fig"}). This result indicated that this sensor could work in different strains to sense the different levels of the amount of intracellular VB~12~ by producing corresponding levels of fluorescence intensity. Moreover, a corresponding rise in GFP fluorescence values of *Sm320-N8* strains carrying SY-btuB sensor double plasmids could be observed by increasing VB~12~ concentration in the medium (Additional file [1](#MOESM1){ref-type="media"}: Figure S3).

Next, we simulated a screening process to verify the reliability of the sensor-reporter. The three strains with different production capacities were mixed together at equal optical density and the mixture of strains was used for screening with FCAS. Colonies exhibiting the top 1% of fluorescence values were analyzed to evaluate the sorting performance of the SY-btuB sensor double plasmid (Summit 5.2 analysis). As expected, nearly 84% of sorted cells were identified as the high-producing *Sm320* strain (Fig. [5c](#Fig5){ref-type="fig"}). Overall, *Sm320-Mybi* represented the best regulatory device, and the strain *Sm320-Mybi* was used in the subsequent experiments.

High throughput screening of mutants using riboswitch {#Sec15}
-----------------------------------------------------

ARTP-irradiation was used to induce random mutations, and high VB~12~-producing mutants were selected. Growing cells were treated with helium-based ARTP for 15, 30, 60, 75, 90 and 120 s, respectively. The lethality rate was over 80% when the exposure time exceeded 60 s, and there was no cell survival after 120 s treatment (Fig. S4). Therefore, the optimal exposure time used in subsequent studies was set at 60 s with lethality ranged from 80 to 85%.

We then attempted to screen hyperproducing strains from a library of variant strains using the engineered riboswitch. After treatment of ARTP, selection was carried out using the "dual-repression" SY-btuB riboswitch. Colonies exhibiting the top 0.1% of fluorescence signals were selected from the genetic library. The wild type strain and the mutants were cultured in LB/MC medium in a 96-well microtiter plate at 30 °C for 12 h and then transferred to fresh medium for fermentation in 24-well deep plate at 30 °C with shaking for 7 days.

After 3 rounds of mutation and screening, a total of 144 colonies were selected from the genetic library containing roughly 6 × 10^7^ mutants. After fermentation in 24-well plates, 58.3% (84/144) of the mutants produced higher VB~12~ levels than the initial strains (Fig. [6](#Fig6){ref-type="fig"}). Six mutants (*MD1--6, MB3--5, MD3--2 MC4--5, MB5--1,* and *MC5--2*) showed a significant enhancement of 10% in their VB~12~ content compared with the initial strains. These mutants were then cultured in 250 mL flasks at 30 °C with shaking for 7 days. The mutant MC*5--2* showed VB~12~ production of 156 ± 4.2 mg/L, which was 21.82% higher than the wild-type strain. After 7-generation cultivation, mutant *MC5--2* still maintained high VB~12~ yield reaching to 154 ± 3.2 mg/L. The VB~12~ titer of *MD3--2* was the second highest among the mutants with an increase of 20.31% than that of the wild-type strain.Fig. 6VB~12~ concentration of *Sm320* mutants obtained with ARTP treatments. "W" indicates the wild-type strain of *S. meliloti* with a VB~12~ content of 108 mg/L in a 24-well deep plate at 30 °C for 7 d. The solid line indicates the original strain, and the dotted line indicates the position where the VB~12~ content increased 10% compared with the original strain. Error bars show the means of three independent fermentation cultures for each strain by HPLC analysis

Whole genome sequencing analyses {#Sec16}
--------------------------------

To identify the gene mutations contributing to the high VB~12~ production, we sequenced the genomic DNA of the mutant *Sm320MC5--2*. The gene mutations were identified from the sequence data. A total of 17 SNP (single nucleotide polymorphism) and 1 Indel (insertion and deletion) were identified in the *Sm320MC5--2* genome (Additional file [1](#MOESM1){ref-type="media"}: Table S3). Genome-scale gene expression analysis of *Sm320* and *Sm320MC5--2* revealed that the mutant genes were located in the VB~12~ metabolic pathway, heme branch pathway, ABC transporters, VB~12~ precursor synthesis pathway, tricarboxylic acid cycle and other metabolic pathways. These SNPs functioned through altering the transcription level or enzyme activities and may have resulted in enhanced metabolic flux towards production of VB~12~ or by weakening the competing branches. This study demonstrates a new paradigm of revealing unexpected gene mutations to guide metabolic engineering for increasing VB~12~ yield.

Discussion {#Sec17}
==========

In the past few years, various mRNA elements containing engineered riboswitches and reporter genes have been described and applied in modulating genetic switches, discovering the genetic pathway and optimizing cellular behaviors. However, none of simple and direct metabolite sensors has been applied in screening to increase the yield and productivity of target molecules. In this study, we reported successful application of a riboswitch sensor as a sensitive and novel detection method for VB~12~ screening. Moreover, we identified a VB~12~ riboswitch element that is responsible for expression of the VB~12~ transporter, *btuB*, in the genome of *Salmonella typhimurium* \[[@CR29]\]. We validated the applicability of this riboswitch by screening higher VB~12~ producers from a genetic DNA library.

It is necessary to emphasize that the titer of VB~12~ was heavily dependent on the culture conditions. In our previous study, we did some research to select the nitrogen source, considering the sediment of CSL may interfere the accuracy of the experiments, we replaced the nitrogen sources "2% CSL" by "2% AYP, 1% peptone" in the fermentation medium when the strains were screened by FACS, and the comparison was shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S5. When the strains were cultivated on shake flasks, VB~12~ was produced at millimolar concentrations. But when the strains were screened by FACS, the amount of intracellular VB~12~ was only about 1.06 μg/mL (micromolar levels of B~12~). So, the levels of VB~12~ produced could be detected by riboswitch normally.

In this study, 156 ± 4.2 mg/L of VB~12~ was produced by the selected mutant *MC5--2.* In order to identify gene mutations that contributed to the high production of VB~12~, we sequenced the genomic DNA of the mutant *Sm320MC5--2* Many gene mutations in *Sm320MC5--2* genome may play key roles in the VB~12~ hyperproduction. The SNPs in *hemin, hemN, sdhA, betB, ribH,* and *metH* were not reported in *S. meliloti*. These SNPs may alter transcription levels and enzyme activities to enhance metabolic flux towards producing VB~12~ or weakening the competing branches to improve productivity.

There were two changes identified in the heme branch pathway, mutation of *hemin* (c.C1228T: p.H410Y) and *hemN* (c.C632T: p.T211I). The mutation of *hemN* is speculated to decrease urinary porphyrins original III metabolic flow to the synthesis of hemoglobin leading to increasing productivity of VB~12~. The gene *hemin* encodes an iron complex transport system substrate-binding protein, and its mutation may decrease the active efflux of hemoglobin, reducing the heme anabolic flow to maintain the cell intracellular requirement.

In addition, we speculate that the mutation of *sdhA* (c.G1846A:p.A616T) in the tricarboxylic acid cycle conversion of succinate as carbon sources is necessary but insufficient for the VB~12~ metabolic pathways. The mutant of *betB* (c.T301C:p.W101R) gene may enhance the utilization of betaine to improve VB~12~ productivity. The *ribH* (c.T95C:p.L32P) encodes riboflavin kinase in riboflavin metabolism and may play a key role in 5, 6-dimethylbenzimidazo-le (DMB) synthesis, a precursor of VB~12~ biosynthesis.

Finally, one cobalamin-dependent enzyme in *S. meliloti*, methionine synthase (MetH c.G733A:p.G245S), catalyzes the final step in methionine biosynthesis and is required for growth \[[@CR30]\]. In future work, the contribution of these enzymes to VB~12~ production needs to be determined, which may help elucidate the underlying mechanism and analyze metabolic circuits for further improvement of VB~12~ production in *S. meliloti*.

Conclusions {#Sec18}
===========

We developed a Vitamin B~12~ high-throughput screening system by riboswitch sensor for the selection of VB~12~hyperproducing strains. The *S. meliloti* mutant library was generated by ARTP. Numerous mutants were obtained, and *Sm320MC5--2* exhibited 21.82% higher VB~12~ yield than the wild type strain. The genomic DNA of the hyperproducing mutant was subjected to whole genome sequencing, and the potential contributions of the gene mutations were discussed. This study provides a new paradigm in high throughput screening and elucidating the unexpected gene mutations which would be helpful for rewiring metabolic pathway to raise the yield of VB~12~.
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